{"count": 32, "results": [{"_id": "34769067", "pmid": 34769067, "pmcid": "PMC8583878", "title": "Increased Post-Hypoxic Oxidative Stress and Activation of the PERK Branch of the UPR in Trap1-Deficient Drosophila melanogaster Is Abrogated by Metformin", "journal": "Int J Mol Sci", "authors": ["Kokott-Vuong A", "Jung J", "Fehr AT", "Kirschfink N", "Noristani R", "Voigt A", "Reich A", "Schulz JB", "Huber M", "Habib P"], "date": "2021-10-28T00:00:00Z", "doi": "10.3390/ijms222111586", "meta_date_publication": "2021 Oct 28", "meta_volume": "22", "meta_issue": "21", "meta_pages": "", "score": 50267.598, "text_hl": "Increased Post-@<m>DISEASE_Hypoxia_Brain</m> @DISEASE_MESH:D002534 @@@Hypoxic@@@ Oxidative Stress and Activation of the @GENE_RL @GENE_3354888 @@@PERK@@@ Branch of the UPR in @GENE_TRAP1 @GENE_35559 @@@Trap1@@@-Deficient @SPECIES_7227 @@@Drosophila melanogaster@@@ Is Abrogated by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@", "citations": {"NLM": "Kokott-Vuong A, Jung J, Fehr AT, Kirschfink N, Noristani R, Voigt A, Reich A, Schulz JB, Huber M, Habib P. Increased Post-Hypoxic Oxidative Stress and Activation of the PERK Branch of the UPR in Trap1-Deficient Drosophila melanogaster Is Abrogated by Metformin Int J Mol Sci. 2021 Oct 28;22(21):. PMID: 34769067", "BibTeX": "@article{34769067, title={Increased Post-Hypoxic Oxidative Stress and Activation of the PERK Branch of the UPR in Trap1-Deficient Drosophila melanogaster Is Abrogated by Metformin}, author={Kokott-Vuong A and Jung J and Fehr AT and Kirschfink N and Noristani R and Voigt A and Reich A and Schulz JB and Huber M and Habib P}, journal={Int J Mol Sci}, volume={22}, number={21}}"}}, {"_id": "40490245", "pmid": 40490245, "title": "Effect of metformin on spontaneous calcium signaling in cultured astrocytes during normoxic and hypoxic conditions.", "journal": "Arch Biochem Biophys", "authors": ["Svirskiene N", "Svirskis G", "Jankeviciute S", "Borutaite V"], "date": "2025-06-07T00:00:00Z", "doi": "10.1016/j.abb.2025.110494", "meta_date_publication": "2025 Jun 7", "meta_volume": "771", "meta_issue": "", "meta_pages": "110494", "score": 50263.344, "text_hl": "Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on spontaneous @CHEMICAL_Calcium @CHEMICAL_MESH:D002118 @@@calcium@@@ signaling in cultured astrocytes during normoxic and @<m>DISEASE_Hypoxia_Brain</m> @DISEASE_MESH:D002534 @@@hypoxic@@@ conditions.", "citations": {"NLM": "Svirskiene N, Svirskis G, Jankeviciute S, Borutaite V. Effect of metformin on spontaneous calcium signaling in cultured astrocytes during normoxic and hypoxic conditions. Arch Biochem Biophys. 2025 Jun 7;771():110494. PMID: 40490245", "BibTeX": "@article{40490245, title={Effect of metformin on spontaneous calcium signaling in cultured astrocytes during normoxic and hypoxic conditions.}, author={Svirskiene N and Svirskis G and Jankeviciute S and Borutaite V}, journal={Arch Biochem Biophys}, volume={771}, pages={110494}}"}}, {"_id": "32883003", "pmid": 32883003, "pmcid": "PMC7565921", "title": "Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells", "journal": "Cancers (Basel)", "authors": ["Samuel SM", "Varghese E", "Koklesová L", "Líšková A", "Kubatka P", "Büsselberg D"], "date": "2020-09-01T00:00:00Z", "doi": "10.3390/cancers12092482", "meta_date_publication": "2020 Sep 1", "meta_volume": "12", "meta_issue": "9", "meta_pages": "", "score": 50256.48, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ selectively targets CSCs and improves the @<m>DISEASE_Hypoxia_Brain</m> @DISEASE_MESH:D002534 @@@hypoxic@@@ microenvironment, suppresses the @DISEASE_Neoplasm_Metastasis @DISEASE_MESH:D009362 @@@tumor metastasis@@@ and @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@, as well as regulates the metabolic programming, induces apoptosis, and reverses epithelial-mesenchymal transition and @DISEASE_Tuberculosis_Multidrug_Resistant @DISEASE_MESH:D018088 @@@MDR@@@. ", "citations": {"NLM": "Samuel SM, Varghese E, Koklesová L, Líšková A, Kubatka P, Büsselberg D. Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells Cancers (Basel). 2020 Sep 1;12(9):. PMID: 32883003", "BibTeX": "@article{32883003, title={Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells}, author={Samuel SM and Varghese E and Koklesová L and Líšková A and Kubatka P and Büsselberg D}, journal={Cancers (Basel)}, volume={12}, number={9}}"}}, {"_id": "40850908", "pmid": 40850908, "title": "Safety and feasibility trial protocol of metformin in infants after perinatal brain injury.", "journal": "BMJ Paediatr Open", "authors": ["Hutchinson AM", "Pais R", "Endginton AN", "Pilon B", "MacDonald JM", "MacDonald ME", "Lewis T", "Offringa M", "Kalish BT"], "date": "2025-08-24T00:00:00Z", "doi": "10.1136/bmjpo-2024-002784", "meta_date_publication": "2025 Aug 24", "meta_volume": "9", "meta_issue": "1", "meta_pages": "", "score": 50255.305, "text_hl": "Herein, we describe a clinical trial of the safety, feasibility and pharmacokinetics of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in infants with @<m>DISEASE_Hypoxia_Brain</m> @DISEASE_MESH:D002534 @@@HIE@@@.  ", "citations": {"NLM": "Hutchinson AM, Pais R, Endginton AN, Pilon B, MacDonald JM, MacDonald ME, Lewis T, Offringa M, Kalish BT. Safety and feasibility trial protocol of metformin in infants after perinatal brain injury. BMJ Paediatr Open. 2025 Aug 24;9(1):. PMID: 40850908", "BibTeX": "@article{40850908, title={Safety and feasibility trial protocol of metformin in infants after perinatal brain injury.}, author={Hutchinson AM and Pais R and Endginton AN and Pilon B and MacDonald JM and MacDonald ME and Lewis T and Offringa M and Kalish BT}, journal={BMJ Paediatr Open}, volume={9}, number={1}}"}}, {"_id": "36037303", "pmid": 36037303, "title": "A Phase II Randomized Trial of Chemoradiation with or without Metformin in Locally Advanced Cervical Cancer.", "journal": "Clin Cancer Res", "authors": ["Han K", "Fyles A", "Shek T", "Croke J", "Dhani N", "D'Souza D", "Lee TY", "Chaudary N", "Bruce J", "Pintilie M", "Cairns R", "Vines D", "Pakbaz S", "Jaffray D", "Metser U", "Rouzbahman M", "Milosevic M", "Koritzinsky M"], "date": "2022-12-15T00:00:00Z", "doi": "10.1158/1078-0432.CCR-22-1665", "meta_date_publication": "2022 Dec 15", "meta_volume": "28", "meta_issue": "24", "meta_pages": "5263-5271", "score": 50253.84, "text_hl": "CONCLUSIONS: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ decreased @DISEASE_Uterine_Cervical_Neoplasms @DISEASE_MESH:D002583 @@@cervical tumor hypoxia@@@ in this trial that selected for @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Hypoxia_Brain</m> @DISEASE_MESH:D002534 @@@hypoxic tumor@@@. ", "citations": {"NLM": "Han K, Fyles A, Shek T, Croke J, Dhani N, D'Souza D, Lee TY, Chaudary N, Bruce J, Pintilie M, Cairns R, Vines D, Pakbaz S, Jaffray D, Metser U, Rouzbahman M, Milosevic M, Koritzinsky M. A Phase II Randomized Trial of Chemoradiation with or without Metformin in Locally Advanced Cervical Cancer. Clin Cancer Res. 2022 Dec 15;28(24):5263-5271. PMID: 36037303", "BibTeX": "@article{36037303, title={A Phase II Randomized Trial of Chemoradiation with or without Metformin in Locally Advanced Cervical Cancer.}, author={Han K and Fyles A and Shek T and Croke J and Dhani N and D'Souza D and Lee TY and Chaudary N and Bruce J and Pintilie M and Cairns R and Vines D and Pakbaz S and Jaffray D and Metser U and Rouzbahman M and Milosevic M and Koritzinsky M}, journal={Clin Cancer Res}, volume={28}, number={24}, pages={5263-5271}}"}}, {"_id": "32951587", "pmid": 32951587, "title": "The Chemosensitizing Role of Metformin in Anti-Cancer Therapy.", "journal": "Anticancer Agents Med Chem", "authors": ["Tang Z", "Tang N", "Jiang S", "Bai Y", "Guan C", "Zhang W", "Fan S", "Huang Y", "Lin H", "Ying Y"], "date": "2021-01-01T00:00:00Z", "doi": "10.2174/1871520620666200918102642", "meta_date_publication": "2021", "meta_volume": "21", "meta_issue": "8", "meta_pages": "949-962", "score": 50252.465, "text_hl": "A growing body of evidence indicates that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can sensitize @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ responses to different chemotherapeutic drugs, such as hormone modulating drugs, anti-metabolite drugs, antibiotics, and DNA-damaging drugs via selective targeting of @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@Cancer@@@ Stem Cells (CSCs), improving the @<m>DISEASE_Hypoxia_Brain</m> @DISEASE_MESH:D002534 @@@hypoxic@@@ microenvironment, and by suppressing @DISEASE_Neoplasm_Metastasis @DISEASE_MESH:D009362 @@@tumor metastasis@@@ and @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@. ", "citations": {"NLM": "Tang Z, Tang N, Jiang S, Bai Y, Guan C, Zhang W, Fan S, Huang Y, Lin H, Ying Y. The Chemosensitizing Role of Metformin in Anti-Cancer Therapy. Anticancer Agents Med Chem. 2021;21(8):949-962. PMID: 32951587", "BibTeX": "@article{32951587, title={The Chemosensitizing Role of Metformin in Anti-Cancer Therapy.}, author={Tang Z and Tang N and Jiang S and Bai Y and Guan C and Zhang W and Fan S and Huang Y and Lin H and Ying Y}, journal={Anticancer Agents Med Chem}, volume={21}, number={8}, pages={949-962}}"}}, {"_id": "39186177", "pmid": 39186177, "title": "Metformin as a Modulator of Autophagy and Hypoxia Responses in the Enhancement of Wound Healing in Diabetic Rats.", "journal": "Inflammation", "authors": ["Tombulturk FK", "Soydas T", "Kanigur-Sultuybek G"], "date": "2024-08-26T00:00:00Z", "doi": "10.1007/s10753-024-02129-9", "meta_date_publication": "2024 Aug 26", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50251.797, "text_hl": "Herein, we investigated the role of topical @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, an established anti-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ drug with potential autophagy-inducing properties, in improving wound healing outcomes under @<m>DISEASE_Hypoxia_Brain</m> @DISEASE_MESH:D002534 @@@hypoxic@@@ conditions. ", "citations": {"NLM": "Tombulturk FK, Soydas T, Kanigur-Sultuybek G. Metformin as a Modulator of Autophagy and Hypoxia Responses in the Enhancement of Wound Healing in Diabetic Rats. Inflammation. 2024 Aug 26;():. PMID: 39186177", "BibTeX": "@article{39186177, title={Metformin as a Modulator of Autophagy and Hypoxia Responses in the Enhancement of Wound Healing in Diabetic Rats.}, author={Tombulturk FK and Soydas T and Kanigur-Sultuybek G}, journal={Inflammation}}"}}, {"_id": "37385610", "pmid": 37385610, "title": "Effects of plateau hypoxia on population pharmacokinetics and pharmacodynamics of metformin in patients with Type 2 diabetes.", "journal": "Zhong Nan Da Xue Xue Bao Yi Xue Ban", "authors": ["Shen Y", "Luo X", "Qin N", "Hu L", "Luo L", "Wang Z", "Sun Y", "Wang R", "Li W"], "date": "2023-04-28T00:00:00Z", "doi": "10.11817/j.issn.1672-7347.2023.220267", "meta_date_publication": "2023 Apr 28", "meta_volume": "48", "meta_issue": "4", "meta_pages": "481-490", "score": 50251.367, "text_hl": "...OBJECTIVES: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ is the basic drug for treating @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@, and the plateau @<m>DISEASE_Hypoxia_Brain</m> @DISEASE_MESH:D002534 @@@hypoxic@@@ environment is an important factor affecting the pharmacokinetics of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, but there have been no reports of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ pharmacokinetic parameters in patients with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@diabetes mellitus type 2@@@ (@DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@) in the high-altitude @<m>DISEASE_Hypoxia_Brain</m> @DISEASE_MESH:D002534 @@@hypoxic@@@ environment. ", "citations": {"NLM": "Shen Y, Luo X, Qin N, Hu L, Luo L, Wang Z, Sun Y, Wang R, Li W. Effects of plateau hypoxia on population pharmacokinetics and pharmacodynamics of metformin in patients with Type 2 diabetes. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Apr 28;48(4):481-490. PMID: 37385610", "BibTeX": "@article{37385610, title={Effects of plateau hypoxia on population pharmacokinetics and pharmacodynamics of metformin in patients with Type 2 diabetes.}, author={Shen Y and Luo X and Qin N and Hu L and Luo L and Wang Z and Sun Y and Wang R and Li W}, journal={Zhong Nan Da Xue Xue Bao Yi Xue Ban}, volume={48}, number={4}, pages={481-490}}"}}, {"_id": "31672491", "pmid": 31672491, "title": "Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways.", "journal": "Cancer Lett", "authors": ["Nan X", "Wang J", "Cheng H", "Yin Z", "Sheng J", "Qiu B", "Lau CC", "Yustein JT", "Zhao H", "Wong STC"], "date": "2020-01-28T00:00:00Z", "doi": "10.1016/j.canlet.2019.10.034", "meta_date_publication": "2020 Jan 28", "meta_volume": "469", "meta_issue": "", "meta_pages": "195-206", "score": 50250.36, "text_hl": "@CHEMICAL_Imatinib_Mesylate @CHEMICAL_MESH:D000068877 @@@Imatinib@@@ revives the therapeutic potential of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @DISEASE_Sarcoma_Ewing @DISEASE_MESH:D012512 @@@ewing sarcoma@@@ by attenuating @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ @<m>DISEASE_Hypoxia_Brain</m> @DISEASE_MESH:D002534 @@@hypoxic@@@ response and inhibiting convergent signaling pathways.", "citations": {"NLM": "Nan X, Wang J, Cheng H, Yin Z, Sheng J, Qiu B, Lau CC, Yustein JT, Zhao H, Wong STC. Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways. Cancer Lett. 2020 Jan 28;469():195-206. PMID: 31672491", "BibTeX": "@article{31672491, title={Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways.}, author={Nan X and Wang J and Cheng H and Yin Z and Sheng J and Qiu B and Lau CC and Yustein JT and Zhao H and Wong STC}, journal={Cancer Lett}, volume={469}, pages={195-206}}"}}, {"_id": "37147018", "pmid": 37147018, "pmcid": "PMC10163559", "title": "Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression", "journal": "J Immunother Cancer", "authors": ["Finisguerra V", "Dvorakova T", "Formenti M", "Van Meerbeeck P", "Mignion L", "Gallez B", "Van den Eynde BJ"], "date": "2023-05-01T00:00:00Z", "doi": "10.1136/jitc-2022-005719", "meta_date_publication": "2023 May", "meta_volume": "11", "meta_issue": "5", "meta_pages": "", "score": 50249.12, "text_hl": "Given these results we sought to investigate whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ could improve @GENE_CD8A @GENE_925 @@@CD8@@@ T-cell fitness in vivo in @<m>DISEASE_Hypoxia_Brain</m> @DISEASE_MESH:D002534 @@@hypoxic tumors@@@. ", "citations": {"NLM": "Finisguerra V, Dvorakova T, Formenti M, Van Meerbeeck P, Mignion L, Gallez B, Van den Eynde BJ. Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression J Immunother Cancer. 2023 May;11(5):. PMID: 37147018", "BibTeX": "@article{37147018, title={Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression}, author={Finisguerra V and Dvorakova T and Formenti M and Van Meerbeeck P and Mignion L and Gallez B and Van den Eynde BJ}, journal={J Immunother Cancer}, volume={11}, number={5}}"}}]}